Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 1431-1440 of 2905 for cancer

Edit search filters
  1. A Trial Of Enzastaurin Plus Temozolomide During And Following Radiation Therapy In Patients With Newly Diagnosed Glioblastoma With Or Without The Novel Genomic Biomarker, DGM1

    Scottsdale/Phoenix, AZ, Jacksonville, FL, Rochester, MN

  2. A Study To Assess The Effectiveness And Safety Of Ublituximab In Combination With Umbralisib And Venetoclax (U2-V) Compared To Ublituximab And Umbralisib (U2) In Subjects With Chronic Lymphocytic Leukemia (CLL)

    Jacksonville, FL, Rochester, MN

  3. SL-401 In Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Hypereosinoophic Disorder, Chronic Myelomonocytic Leukemia)

    Jacksonville, FL, Rochester, MN

  4. A Study To Evaluate Ipilimumab Administered Intra-lymphatically Using The Sofusa® DoseConnect™ DEVICE With IV-administered Nivolumab In Patients With Metastatic Melanoma

    Rochester, MN

  5. Ibrutinib In Treating Minimal Residual Disease In Patients With Chronic Lymphocytic Leukemia After Front-Line Therapy

    Jacksonville, FL

  6. A Trial Of TTI-621 For Patients With Hematologic Malignancies And Selected Solid Tumors

    Jacksonville, FL, Rochester, MN

  7. MR-Guided Cryoablation Of Prostate Bed Recurrences

    Rochester, MN

  8. A Study To Evaluate Encapsulated Rapamycin To Prevent Progression Of Familial Adenomatous Polyposis In Patients

    Scottsdale/Phoenix, AZ

  9. A Study Of SAR442085 In Relapsed Or Refractory Multiple Myeloma

    Rochester, MN

  10. A Study To Evaluate Gleolan To Enhance Tumor Visualization In Patients With Newly-diagnosed Or Recurrent Meningioma

    Scottsdale/Phoenix, AZ, Rochester, MN

.

Mayo Clinic Footer